A common substitution (Asn291Ser) in lipoprotein lipase is associated with increased risk of ischemic heart disease

Journal of Clinical Investigation

Volumn 99, Issue 7, 1997, Pages 1606-1613

  Wittrup, Hans H ^a   Tybjærg Hansen, Anne ^a,b   Abildgaard, Susanne ^a   Steffensen, Rolf ^b   Schnohr, Peter ^b   Nordestgaard, Børge G ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b University of Copenhagen   (Denmark)

Author keywords

atherosclerosis; HDL; molecular epidemiology; polymorphism; triglycerides

Indexed keywords

LIPOPROTEIN LIPASE;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; FEMALE; GENETIC RISK; GENETIC VARIABILITY; HUMAN; ISCHEMIC HEART DISEASE; LIPOPROTEIN METABOLISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0030896983     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119323     Document Type: Article

References (25)

1. Brunzell, J. 1995. Familial lipoprotein lipase deficiency and other causes of the chylomicronemia syndrome. In The Metabolic and Molecular Bases of Inherited Disease. 7th ed. C. Scriver, A. Beaudet, W. Sly, and D. Valle, editors. McGraw-Hill Inc., New York. 1913-1932.
2. Olivecrona, G., and T. Olivecrona. 1995. Triglyceride lipases and atherosclerosis. Curr. Opin. Lipidol. 6:291-305.
3. Benlian, P., J.L.D. Gennes, L., Fouhert, H. Zhang, S.E. Gagné, and M. Hayden. 1996. Premature atherosclerosis in patients with familial chylomicronemia caused by mutations in the lipoprotein lipase gene. N. Engl. J. Med. 335: 848-854.
4. Ma, Y., T.C. Ooi, M.S. Liu, H. Zhang, R. McPherson, A.L. Edwards, I.J. Forsythe, J. Frohlich, J.D. Brunzell, and M.R. Hayden. 1994. High frequency of mutations in the human lipoprotein lipase gene in pregnancy-induced chylomicronemia: possible association with apolipoprotein E2 isoform. J. Lipid Res. 35: 1066-1075.
5. Minnich, A., A. Kessling, M. Roy, C. Giry, G. DeLangavant, J. Lavigne, S. Lussier-Cacan, and J. Davignon. 1995. Prevalence of alleles encoding defective lipoprotein lipase in hypertriglyceridemic patients of French Canadian descent. J. Lipid Res. 36:117-124.
6. Reymer, P.W., E. Gagné. B.E. Groenemeyer, H. Zhang, I. Forsyth, H. Jansen, J. C. Seidell, D. Kromhout, K.E. Lie, J. Kastelein, and M.R. Hayden. 1995. A lipoprotein lipase mutation (Asn291Ser) is associated with reduced HDL cholesterol levels in premature atherosclerosis. Nat. Genet. 10:28-34.
7. Fisher, R.M., F. Mailly, R.E. Peacock, A. Hamsten, M. Seed, J.S. Yudkin, U. Beisiegel G. Feussner, G. Miller, S.E. Humphries, and P.J. Talmud. 1995. Interaction of the lipoprotein lipase asparagine 291→serine mutation with body mass index determines elevated plasma triacylglycerol concentrations: a study in hyperlipidemic subjects, myocardial infarction survivors, and healthy adults. J. Lipid Res. 36:2104-2112.
8. Jemaa R., F. Fumeron, O. Poirier, L. Lecerf, A. Evans, D. Arveiler, G. Luc, J.-P. Cambou, J.-M. Bard, J.-C. Fruchart, et al. 1995. Lipoprotein lipase gene polymorphisms: associations with myocardial infarction and lipoprotein levels, the ECTIM study. J. Lipid Res. 36:2141-2146.
9. Gordon, D.J., J.L. Probstfield, R.J. Garrison, J.D. Neaton, W.P. Castelli, J.D. Knoke, D.R. Jacobs, Jr., S. Bangdiwala, and H.A. Tyroler. 1989. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation. 79:8-15.
10. Austin, M.A. 1991. Plasma triglyceride and coronary heart disease. Arterioscler. Thromb. 11:2-14.
11. Goldberg, I.J. 1996. Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis. J. Lipid Res. 37:693-707.
12. Appleyard, M., A.T. Hansen, P. Schnohr, G. Jensen, and J. Nyboe. 1989. The Copenhagen City Heart Study, Østerbroundersøgelsen. A book of tables with data from the first examination (1976-78) and a five year follow-up (1981-83). Scand. J. Soc. Med. Suppl. 41:1-160.
13. Talmud, P., A. Tybjaerg-Hansen, D. Bhatnagar, A. Mbewu, J.P. Miller, P. Durrington, and S. Humphries. 1991. Rapid screening for specific mutations in patients with a clinical diagnosis of familial hypercholesterolaemia. Atherosclerosis. 89:137-141.
14. Zhang, H., P.W.A. Reymer, M.-S. Liu, I.J. Forsythe, B.E. Groenemeyer, J. Frohlich, J.D. Brunzell, J.J.P. Kastelein, M.R. Hayden, and Y. Ma. 1995. Patients with apoE3 deficiency (E2/2, E3/2, and E4/2) who manifest with hyperlipidemia have increased frequency of an Asn 291→Ser mutation in the human LPL gene. Arterioscler. Thromb. Vasc. Biol. 15:1695-1703.
15. SPSS for Windows. 1993. Base System User's Guide, release 6.0. Norusis, M. J. and SPSS Inc. 6.0 USA. SPSS Inc.
16. Hosmer, D.W., and S. Lemeshow. 1989. Model-building strategies and methods for logistic regression. In Applied Logistic Regression. John Wiley & Sons, New York. 82-134.
17. Menard, S. 1995. An introduction to logistic regression diagnostics. In Applied Logistic Regression Analysis. Sage Publications, Inc., Thousand Oaks, CA. 58-79.
18. Beaudet, A.L., C.R. Scriver, W.S. Sly, and D. Valle. 1995. Genetics, biochemistry, and molecular basis of variant human phenotypes. In The Metabolic & Molecular Bases of Inherited Disease. 7th ed. C.R. Scriver, A.L. Beaudet, W.S. Sly, and D. Valle, editors. McGraw-Hill Inc., New York. 53-118.
19. Nordestgaard, B. G., R. Wootton, and B. Lewis. 1995. Selective retention of VLDL, IDL, and LDL in the arterial intima of genetically hyperlipidemic rabbits in vivo. Molecular size as a determinant of fractional loss from the intima-inner media. Arterioscler. Thromb. Vasc. Biol. 15:534-542.
20. Barter, P.J., and K.-A. Rye. 1996. High density lipoproteins and coronary heart disease. Atherosclerosis. 121:1-12.
21. Reymer, P.W.A., B.E. Groenemeyer, E. Gagné, L. Miao, E.E.G. Appelman, J.C. Seidel, D. Kromhout, S.M. Bijvoet, K. van de Oever, T. Bruin, et al. 1995. A frequently occurring mutation in the lipoprotein lipase gene (Asn291Ser) contributes to the expression of familial combined hyperlipidemia. Hum. Mol. Genet. 4:1543-1549.
22. Hoffer, M.J.V., S.J.H. Bredie, D.I. Boomsma, P.W.A. Reymer, J.J. P. Kastelein, P. de Knijff, P.N.M. Demacker, A.F.H. Stalenhoef, L.M. Havekes, and R.R. Frants. 1996. The lipoprotein lipase (Asn291→Ser) mutation is associated with elevated lipid levels in families with familial combined hyperhpidemia. Atherosclerosis. 119:159-167.
23. Funke, H., and G. Assmann. 1995. The low down on lipoprotein lipase. Nat. Genet. 10:6-7.
24. Busca, R., J. Peinado, E. Vilella, J. Auwerx, S.S. Deeb, S. Vilaro, and M. Reina. 1995. The mutant Asn291→Ser human lipoprotein lipase is associated with reduced catalytic activity and does not influence binding to heparin. FEBS Lett. 367:257-262.
25. 291→Ser mutation in the lipoprotein lipase gene in two Finnish pedigrees: effect of hyperinsulinemia on the expression of hypertriglyceridemia. J. Lipid Res. 37:727-738.